Cuprina Holdings (Cayman) LTD — Investor Relations & Filings

Cuprina Holdings is a biomedical and biotechnology company specializing in the development and commercialization of innovative wound care solutions and cosmeceuticals. The company's core product line, MEDIFLY, utilizes Maggot Debridement Therapy (MDT), a biotherapy that employs sterile, medical-grade blowfly larvae for the non-surgical removal of necrotic tissue from chronic wounds like diabetic foot ulcers. This process is designed to accelerate healing, disinfect the wound, and promote healthy tissue growth, with a key application in limb salvage. The company's portfolio also includes complementary wound care products, such as the ANURAN collagen scaffold, and consumer-focused brands for skin restoration and athletic care.